[ad_1]
UK Launches Pfizer AstraZeneca Vaccine Approval Process
United States and Pfizer, Modena and AstraZeneca secure a vaccination contract
The European Union ensures sufficient doses for local citizens
US FDA less likely to approve AstraZeneca vaccine, efficacy controversial
Trump “The Corona 19 vaccine will be available starting next week”
[앵커]
The United States and Europe are accelerating the development and procurement of a COVID-19 vaccine President Trump has vowed to begin supplying the vaccine next week, and the European Union is also raising expectations for an early supply. Reporter Kang Seong-ok reports The UK government has entered the approval process for the AstraZeneca vaccine from the University of Oxford following the Corona 19 vaccine developed by Pfizer-Bioentech. Prime Minister Boris Johnson also visited a laboratory to express expectations for an early supply of vaccines. The United States government is known to have signed a 5 billion won vaccine supply contract with Pfizer, Modena, and AstraZeneca. Europe is also aggressively insuring vaccines. The European Union is reported to have secured a sufficient quantity of vaccine for the people of the region. However, due to the controversy over the efficacy of the vaccine being developed by the University of Oxford and AstraZeneca, it is unlikely that the FDA of the US Food and Drug Administration will grant an emergency license for this vaccine, they predict. major media in the United States. Meanwhile, US President Donald Trump has pledged that delivery of the Corona 19 vaccine will begin next week. It was revealed in a video conference to encourage American troops stationed overseas on Thanksgiving. The US government is in the position that the vaccine can be distributed within 24 hours of FDA approval for emergency use. However, the FDA’s emergency licensing process also requires minimal time, so it seems unlikely that the vaccine supply will begin next week, as President Trump said. This is YTN Kang Seong-ok.
